Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.
This report summarizes barriers and facilitators to providing MOUD at FQHCs and outlines opportunities at the health center, state, and federal level to support the clinical, organizational, and financial capacity to increase access to MOUD.
This case study explores implementation of a medications for opioid use disorder (MOUD) program at an organization in the Bronx, New York with a long history as an opioid treatment program (OTP) that also operates an FQHC and a certified community behavioral health clinic (CCBHC)
This case study explores implementation of medications for opioid use disorder (MOUD) through a federally qualified health center (FQHC) serving as a Health Care for the Homeless (HCH) program in Portland, Maine.
This case study explores implementation of medications for opioid use disorder (MOUD) at a federally qualified health center (FQHC) in rural California that engages with the broader community to address the opioid epidemic.
This report provides an update on the present state of coverage, availability of, and access to, medications for treating ongoing alcohol use disorder and opioid use disorder, and reversing an opioid overdose within state Medicaid plans.
This report, produced in collaboration with the Partnership to End Addiction, analyzes states' parity compliance reporting requirements for mental health and substance use disorder,
This report, produced in collaboration with the Partnership to End Addiction, discusses federal and state regulation and enforcement of the Parity Act with regard to network adequacy for substance use disorder and mental health services.